JP2022024034A5 - - Google Patents

Download PDF

Info

Publication number
JP2022024034A5
JP2022024034A5 JP2021183553A JP2021183553A JP2022024034A5 JP 2022024034 A5 JP2022024034 A5 JP 2022024034A5 JP 2021183553 A JP2021183553 A JP 2021183553A JP 2021183553 A JP2021183553 A JP 2021183553A JP 2022024034 A5 JP2022024034 A5 JP 2022024034A5
Authority
JP
Japan
Prior art keywords
drawings
present application
invention described
application
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021183553A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022024034A (ja
JP7652682B2 (ja
Filing date
Publication date
Priority claimed from JP2020562542A external-priority patent/JP6977185B2/ja
Application filed filed Critical
Publication of JP2022024034A publication Critical patent/JP2022024034A/ja
Publication of JP2022024034A5 publication Critical patent/JP2022024034A5/ja
Priority to JP2025041552A priority Critical patent/JP2025085744A/ja
Application granted granted Critical
Publication of JP7652682B2 publication Critical patent/JP7652682B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021183553A 2018-12-28 2021-11-10 ピロリジン化合物の結晶 Active JP7652682B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025041552A JP2025085744A (ja) 2018-12-28 2025-03-14 ピロリジン化合物の結晶

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2018247437 2018-12-28
JP2018247437 2018-12-28
JP2020562542A JP6977185B2 (ja) 2018-12-28 2019-12-27 ピロリジン化合物の結晶
PCT/JP2019/051570 WO2020138481A1 (ja) 2018-12-28 2019-12-27 ピロリジン化合物の結晶

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020562542A Division JP6977185B2 (ja) 2018-12-28 2019-12-27 ピロリジン化合物の結晶

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025041552A Division JP2025085744A (ja) 2018-12-28 2025-03-14 ピロリジン化合物の結晶

Publications (3)

Publication Number Publication Date
JP2022024034A JP2022024034A (ja) 2022-02-08
JP2022024034A5 true JP2022024034A5 (https=) 2023-01-10
JP7652682B2 JP7652682B2 (ja) 2025-03-27

Family

ID=71127176

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020562542A Active JP6977185B2 (ja) 2018-12-28 2019-12-27 ピロリジン化合物の結晶
JP2021183553A Active JP7652682B2 (ja) 2018-12-28 2021-11-10 ピロリジン化合物の結晶
JP2025041552A Pending JP2025085744A (ja) 2018-12-28 2025-03-14 ピロリジン化合物の結晶

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020562542A Active JP6977185B2 (ja) 2018-12-28 2019-12-27 ピロリジン化合物の結晶

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025041552A Pending JP2025085744A (ja) 2018-12-28 2025-03-14 ピロリジン化合物の結晶

Country Status (8)

Country Link
US (2) US12077524B2 (https=)
EP (3) EP4603143A3 (https=)
JP (3) JP6977185B2 (https=)
CN (3) CN113226314B (https=)
ES (1) ES2991904T3 (https=)
MA (1) MA54619A (https=)
TW (2) TWI870228B (https=)
WO (1) WO2020138481A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230016008A (ko) 2020-06-10 2023-01-31 미쓰비시 타나베 파마 코퍼레이션 광선성 피부질환의 예방 또는 치료제
CA3186880A1 (en) 2020-06-10 2021-12-16 Mitsubishi Tanabe Pharma Corporation Prophylactic or therapeutic agent for porphyria
WO2021251450A1 (ja) 2020-06-10 2021-12-16 田辺三菱製薬株式会社 ポルフィリン症の予防又は治療剤
MX2023013044A (es) * 2021-05-06 2023-11-15 Lg Chemical Ltd Forma cristalina v del compuesto agonista del receptor de melanocortina y metodo para preparar la misma.
BR112023022863A2 (pt) * 2021-05-06 2024-01-23 Lg Chemical Ltd Forma cristalina vii do composto agonista do receptor de melanocortina e método para preparar o mesmo
US20240239769A1 (en) * 2021-05-07 2024-07-18 Lg Chem, Ltd. Co-crystal of melanocortin receptor agonist compound and vanillin and method for preparing same
EP4317148A4 (en) * 2021-05-07 2024-09-18 Lg Chem, Ltd. MELANOCORTIN RECEPTOR AGONIST COMPOUND SULFATE CRYSTALS AND PROCESS FOR PRODUCTION THEREOF
AU2022271120A1 (en) * 2021-05-07 2023-11-09 Lg Chem, Ltd. Crystal form iv of organic acid salts of melanocortin receptor agonist compound, and preparation method thereof
AU2023213357A1 (en) 2022-01-31 2024-08-15 Mitsubishi Tanabe Pharma Corporation Novel use of melanocortin-1 receptor agonist
CN119654150A (zh) 2022-08-03 2025-03-18 田边三菱制药株式会社 含有1-{2-[(3s,4r)-1-{[(3r,4r)-1-环戊基-3-氟-4-(4-甲氧基苯基)吡咯烷-3-基]羰基}-4-(甲氧基甲基)吡咯烷-3-基]-5-(三氟甲基)苯基}哌啶-4-甲酸或其药学上可接受的盐或者共晶的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8143404B2 (en) 2004-09-13 2012-03-27 Ono Pharmaceutical Co., Ltd Nitrogenous heterocylic derivative and medicine containing the same as an active ingredient
CN101365476A (zh) * 2005-10-07 2009-02-11 瓦拉塔药品公司 Dpp-iv抑制剂和胃泌素化合物的联合使用
PL3150578T3 (pl) * 2014-05-29 2021-07-19 Mitsubishi Tanabe Pharma Corporation Nowy związek pirolidynowy i zastosowanie jako agonisty receptora melanokortyny
JP6392297B2 (ja) * 2015-11-27 2018-09-19 田辺三菱製薬株式会社 医薬組成物

Similar Documents

Publication Publication Date Title
JP2023115329A5 (https=)
JP2023518821A5 (https=)
JP2021184963A5 (https=)
JP2025027013A5 (https=)
JP2023171775A5 (https=)
JP2023103258A5 (https=)
JP2022184985A5 (https=)
JP2022024034A5 (https=)
JP2023166402A5 (https=)
JP2022543046A5 (https=)
JP2023526975A5 (https=)
JP2022538797A5 (https=)
JP2023145572A5 (https=)
JP2020010717A5 (https=)
JP2021500894A5 (https=)
JP2021503478A5 (https=)
JP2022541332A5 (https=)
JP2023514727A5 (https=)
JP2021512414A5 (https=)
JP2022523200A5 (https=)
JP2019142968A5 (https=)
JP2023552816A5 (https=)
JP2023181322A5 (https=)
JP2025011142A5 (https=)
JP2024045126A5 (https=)